Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
If enacted, HB 3092 will impose stringent requirements on facilities providing electrodiagnostic services, which must now meet newly established accreditation standards defined by the Secretary of Health. These standards will prioritize the establishment and maintenance of quality assurance programs to ensure the reliability and accuracy of the services provided. Facilities will also be required to have specially trained personnel, thereby promoting better healthcare outcomes for patients and reducing unnecessary treatments and tests.
House Bill 3092, officially titled the ‘Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025’, aims to amend Title XVIII of the Social Security Act. This bill introduces additional requirements for electrodiagnostic services covered under the Medicare program, specifically focusing on nerve conduction studies and needle electromyography tests. Its primary objective is to enhance the quality and reliability of such services and reduce instances of fraud within this sector.
Notable points of contention surrounding the bill include concerns regarding the potential impact on access to care. Opponents may argue that such stringent requirements could limit the number of facilities able to offer these essential services, particularly in rural areas where specialized medical care is already scarce. Advocates for the bill, on the other hand, argue that improving the quality of care and reducing fraud outweighs the potential drawbacks of increased accreditation hurdles.